Synthesis and structural characterization of the formato bridged Cu(ii) cubane: Crystallographic evidence of atmospheric CO2 fixation as formate in a tertranuclear Cu(II) cluster

Kishore, P. R. S.; Jami, Ananda Kumar; Goswami, Anandarup; Tripuramallu, Bharat Kumar; Kishore, Ravada; Kashanna, Jajula

doi:10.1016/j.molstruc.2020.129064

Cited by 2 publications

(1 citation statement)

References 50 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Additionally, a mixture of 1:1 L:Cu(II) complexes was also present, namely, [Cu(PPTP4c4mSe)] + ( m / z : 502.20), [Cu(PPTP4c4mSe)DMSO] + ( m / z : 580.10), and a formate-bridged dimer of [(CuPPTP4c4mSe) 2 (HCOO)] + ( m / z : 1049.40; Figure S6B). The existence of the latter species is supported by previous studies demonstrating the bidentate chelating ability of formate with Cu(II). − As noted above, formic acid is part of the mobile phase of the chromatography column, leading to the formation of the latter dimer. Considering the relative abundance of these Cu(II) transmetalation products after adding Cu(OAc) 2 to [Zn(PPTP4c4mSe)Cl] 2 , the 2:1 L:Cu(II) complex constituted the majority of the Cu complex species (∼90% of total), with the 1:1 L:Cu(II) complexes being a minor fraction (∼10% of total; Figure S7).…”

Section: Resultssupporting

confidence: 58%

Isosteric Replacement of Sulfur to Selenium in a Thiosemicarbazone: Promotion of Zn(II) Complex Dissociation and Transmetalation to Augment Anticancer Efficacy

Kaya,

Gholam Azad,

Suleymanoglu

et al. 2024

J. Med. Chem.

View full text Add to dashboard Cite

We implemented isosteric replacement of sulfur to selenium in a novel thiosemicarbazone (PPTP4c4mT) to create a selenosemicarbazone (PPTP4c4mSe) that demonstrates potentiated anticancer efficacy and selectivity. Their design specifically incorporated cyclohexyl and styryl moieties to sterically inhibit the approach of their Fe(III) complexes to the oxy-myoglobin heme plane. Importantly, in contrast to the Fe(III) complexes of the clinically trialed thiosemicarbazones Triapine, COTI-2, and DpC, the Fe(III) complexes of PPTP4c4mT and PPTP4c4mSe did not induce detrimental oxy-myoglobin oxidation. Furthermore, PPTP4c4mSe demonstrated more potent antiproliferative activity than the homologous thiosemicarbazone, PPTP4c4mT, with their selectivity being superior or similar, respectively, to the clinically trialed thiosemicarbazone, COTI-2. An advantageous property of the selenosemicarbazone Zn(II) complexes relative to their thiosemicarbazone analogues was their greater transmetalation to Cu(II) complexes in lysosomes. This latter effect probably promoted their antiproliferative activity. Both ligands down-regulated multiple key receptors that display inter-receptor cooperation that leads to aggressive and resistant breast cancer.

show abstract